Gut Microbiota, Probiotic Interventions, and Cognitive Function in the Elderly: a Review of Current Knowledge
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Gut Microbiota and Inflammation
International Journal of Environmental Research and Public Health Review The Gut Microbiota and Inflammation: An Overview 1, 2 1, 1, , Zahraa Al Bander *, Marloes Dekker Nitert , Aya Mousa y and Negar Naderpoor * y 1 Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne 3168, Australia; [email protected] 2 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane 4072, Australia; [email protected] * Correspondence: [email protected] (Z.A.B.); [email protected] (N.N.); Tel.: +61-38-572-2896 (N.N.) These authors contributed equally to this work. y Received: 10 September 2020; Accepted: 15 October 2020; Published: 19 October 2020 Abstract: The gut microbiota encompasses a diverse community of bacteria that carry out various functions influencing the overall health of the host. These comprise nutrient metabolism, immune system regulation and natural defence against infection. The presence of certain bacteria is associated with inflammatory molecules that may bring about inflammation in various body tissues. Inflammation underlies many chronic multisystem conditions including obesity, atherosclerosis, type 2 diabetes mellitus and inflammatory bowel disease. Inflammation may be triggered by structural components of the bacteria which can result in a cascade of inflammatory pathways involving interleukins and other cytokines. Similarly, by-products of metabolic processes in bacteria, including some short-chain fatty acids, can play a role in inhibiting inflammatory processes. In this review, we aimed to provide an overview of the relationship between the gut microbiota and inflammatory molecules and to highlight relevant knowledge gaps in this field. -
Gut Health in Veterinary Medicine: a Bibliometric Analysis of the Literature
animals Article Gut Health in Veterinary Medicine: A Bibliometric Analysis of the Literature Elena Colombino 1,*,† , Daniel Prieto-Botella 2,† and Maria Teresa Capucchio 1 1 Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy; [email protected] 2 Department of Surgery and Pathology, Miguel Hernandez University, 03550 Alicante, Spain; [email protected] * Correspondence: [email protected] † Equally contribution. Simple Summary: Gut health has been a main topic in veterinary medicine research after the ban on the use of antimicrobial growth promoters. Gut health has been defined as absence/prevention/avoidance of gastrointestinal disease so that the animal is able to perform its physiological functions. A biblio- metric analysis is a set of statistical methods used to explore trends in the scientific literature such as number of publications, most prolific countries and main research areas to highlight publication dynamics and gaps of knowledge. In this case, a bibliometric analysis was performed on veterinary gut health using the database Web of Science and the R package Bibliometrix. A total of 1696 docu- ments were retrieved between 2000 and 2020, showing an increase of 22.4% in the number of annual publications. Pigs (34.8%), poultry (chicken, duck, turkey and quail—33.9%) and aquaculture (fishes, crustaceans and frog—15.0%) were the most studied species while a scarce number of publications was found on felines, cows, horses, rodents, goats and sheep. China (24.7%), USA (17.2%) and Canada (5.7%) were the most productive countries. Three main research lines aimed to explore animal nutrition, prevention of inflammatory diseases and microbiota composition were identified. -
Bacterial Diversity in the Surface Sediments of the Hypoxic Zone Near
ORIGINAL RESEARCH Bacterial diversity in the surface sediments of the hypoxic zone near the Changjiang Estuary and in the East China Sea Qi Ye, Ying Wu, Zhuoyi Zhu, Xiaona Wang, Zhongqiao Li & Jing Zhang State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China Keywords Abstract Bacteria, Changjiang Estuary, hypoxia, Miseq Illumina sequencing, sediment Changjiang (Yangtze River) Estuary has experienced severe hypoxia since the 1950s. In order to investigate potential ecological functions of key microorgan- Correspondence isms in relation to hypoxia, we performed 16S rRNA-based Illumina Miseq Qi Ye, East China Normal University, State Key sequencing to explore the bacterial diversity in the surface sediments of the Laboratory of Estuarine and Coastal Research, hypoxic zone near the Changjiang Estuary and in the East China Sea (ECS). 3663 North Zhongshan Road, SKLEC Building, Room 419, Shanghai 200062, China. The results showed that numerous Proteobacteria-affiliated sequences in the sedi- Tel: 86-021-52124974; ments of the inner continental shelf were related to both sulfate-reducing and Fax: 86-021- 62546441; sulfur-oxidizing bacteria, suggesting an active sulfur cycle in this area. Many E-mail: [email protected] sequences retrieved from the hypoxic zone were also related to Planctomycetes from two marine upwelling systems, which may be involved in the initial break- Funding Information down of sulfated heteropolysaccharides. Bacteroidetes, which is expected to degrade This study was funded by the Shanghai Pujiang high-molecular-weight organic matter, was abundant in all the studied stations Talent Program (12PJ1403100), the National except for station A8, which was the deepest and possessed the largest grain Natural Science Foundation of China (41276081), the Key Project of Chinese size. -
WO 2016/110768 Al 14 July 2016 (14.07.2016) W P O PCT
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/110768 Al 14 July 2016 (14.07.2016) W P O PCT (51) International Patent Classification: Rue de la Blancherie 11, 1022 Chavannes-pres-Renens A61K 35/74 (2015.01) A61P 25/28 (2006.01) (CH). HANNA, Walid; Avenue des Bains 40, 1007 Lausanne (CH). FAK, Frida; Qvantenborgsvagen 4B, 227 (21) International Application Number: 38 Lund (SE). MARUNGRUANG, Nittaya; Ostra Varvs- PCT/IB2015/059945 gatan 20A, 2 11 75 Malmo (SE). (22) International Filing Date: (74) Agent: ROLAND, Andre; c/o ANDRE ROLAND S.A., 23 December 2015 (23. 12.2015) P.O. Box 5107, 1002 Lausanne (CH). (25) Filing Language: English (81) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (30) Priority Data: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/IB20 15/050 127 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 7 January 2015 (07.01 .2015) IB HN, HR, HU, ID, IL, ΓΝ , IR, IS, JP, KE, KG, KN, KP, KR, PCT/IB2015/053957 27 May 2015 (27.05.2015) IB KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (71) Applicant: ECOLE POLYTECHNIQUE FEDERALE MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, DE LAUSANNE (EPFL) [CH/CH]; EPFL-TTO, EPFL PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, Innovation Park J, 1015 Lausanne (CH). -
British Society of Gastroenterology Guidelines on the Gut: First Published As 10.1136/Gutjnl-2021-324598 on 26 April 2021
Guidelines British Society of Gastroenterology guidelines on the Gut: first published as 10.1136/gutjnl-2021-324598 on 26 April 2021. Downloaded from management of irritable bowel syndrome Dipesh H Vasant ,1,2 Peter A Paine,2,3 Christopher J Black ,4,5 Lesley A Houghton ,5,6 Hazel A Everitt,7 Maura Corsetti,8 Anurag Agrawal,9 Imran Aziz ,10,11 Adam D Farmer,12,13 Maria P Eugenicos,14 Rona Moss- Morris,15 Yan Yiannakou,16 Alexander C Ford 4,5 ► Additional supplemental ABSTRACT (abdominal pain or discomfort, in association material is published online Irritable bowel syndrome (IBS) remains one of the most with altered bowel habit, for at least 6 months, only. To view, please visit the journal online (http:// dx. doi. org/ common gastrointestinal disorders seen by clinicians in in the absence of alarm symptoms or signs) is 10. 1136/ gutjnl- 2021- 324598). both primary and secondary care. Since publication of the more pragmatic and may be more applicable to last British Society of Gastroenterology (BSG) guideline patients with IBS in primary care than diagnostic For numbered affiliations see end of article. in 2007, substantial advances have been made in criteria derived from patients in secondary care, understanding its complex pathophysiology, resulting in such as the Rome IV criteria (recommendation: Correspondence to its re- classification as a disorder of gut- brain interaction, weak, quality of evidence: low). Professor Alexander C Ford, rather than a functional gastrointestinal disorder. ► All patients presenting with symptoms of IBS Leeds Gastroenterology Moreover, there has been a considerable amount of for the first time in primary care should have Institute, St James’s University new evidence published concerning the diagnosis, a full blood count, C reactive protein or eryth- Hospital, Leeds, UK; alexf12399@ yahoo. -
Expanding Diversity of Asgard Archaea and the Elusive Ancestry of Eukaryotes
bioRxiv preprint doi: https://doi.org/10.1101/2020.10.19.343400; this version posted October 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 1 Expanding diversity of Asgard archaea and the elusive ancestry of eukaryotes 2 3 Yang Liu1†, Kira S. Makarova2†, Wen-Cong Huang1†, Yuri I. Wolf2, Anastasia Nikolskaya2, Xinxu 4 Zhang1, Mingwei Cai1, Cui-Jing Zhang1, Wei Xu3, Zhuhua Luo3, Lei Cheng4, Eugene V. Koonin2*, Meng 5 Li1* 6 1 Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen 7 University, Shenzhen, Guangdong, 518060, P. R. China 8 2 National Center for Biotechnology Information, National Library of Medicine, National Institutes of 9 Health, Bethesda, Maryland 20894, USA 10 3 State Key Laboratory Breeding Base of Marine Genetic Resources, Key Laboratory of Marine Genetic 11 Resources, Fujian Key Laboratory of Marine Genetic Resources, Third Institute of Oceanography, State 12 Oceanic Administration, Xiamen 361005, P. R. China 13 4 Key Laboratory of Development and Application of Rural Renewable Energy, Biogas Institute of 14 Ministry of Agriculture, Chengdu 610041, P.R. China 15 † These authors contributed equally to this work. 16 *Authors for correspondence: [email protected] or [email protected] 17 18 19 Running title: Asgard archaea genomics 20 Keywords: 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.19.343400; this version posted October 20, 2020. -
WO 2018/064165 A2 (.Pdf)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. -
Table S4. Phylogenetic Distribution of Bacterial and Archaea Genomes in Groups A, B, C, D, and X
Table S4. Phylogenetic distribution of bacterial and archaea genomes in groups A, B, C, D, and X. Group A a: Total number of genomes in the taxon b: Number of group A genomes in the taxon c: Percentage of group A genomes in the taxon a b c cellular organisms 5007 2974 59.4 |__ Bacteria 4769 2935 61.5 | |__ Proteobacteria 1854 1570 84.7 | | |__ Gammaproteobacteria 711 631 88.7 | | | |__ Enterobacterales 112 97 86.6 | | | | |__ Enterobacteriaceae 41 32 78.0 | | | | | |__ unclassified Enterobacteriaceae 13 7 53.8 | | | | |__ Erwiniaceae 30 28 93.3 | | | | | |__ Erwinia 10 10 100.0 | | | | | |__ Buchnera 8 8 100.0 | | | | | | |__ Buchnera aphidicola 8 8 100.0 | | | | | |__ Pantoea 8 8 100.0 | | | | |__ Yersiniaceae 14 14 100.0 | | | | | |__ Serratia 8 8 100.0 | | | | |__ Morganellaceae 13 10 76.9 | | | | |__ Pectobacteriaceae 8 8 100.0 | | | |__ Alteromonadales 94 94 100.0 | | | | |__ Alteromonadaceae 34 34 100.0 | | | | | |__ Marinobacter 12 12 100.0 | | | | |__ Shewanellaceae 17 17 100.0 | | | | | |__ Shewanella 17 17 100.0 | | | | |__ Pseudoalteromonadaceae 16 16 100.0 | | | | | |__ Pseudoalteromonas 15 15 100.0 | | | | |__ Idiomarinaceae 9 9 100.0 | | | | | |__ Idiomarina 9 9 100.0 | | | | |__ Colwelliaceae 6 6 100.0 | | | |__ Pseudomonadales 81 81 100.0 | | | | |__ Moraxellaceae 41 41 100.0 | | | | | |__ Acinetobacter 25 25 100.0 | | | | | |__ Psychrobacter 8 8 100.0 | | | | | |__ Moraxella 6 6 100.0 | | | | |__ Pseudomonadaceae 40 40 100.0 | | | | | |__ Pseudomonas 38 38 100.0 | | | |__ Oceanospirillales 73 72 98.6 | | | | |__ Oceanospirillaceae -
775 Sixth International Conference on Webometrics, Informetrics And
Sixth International Conference on Webometrics, Informetrics and Scientometrics & Eleventh COLLNET Meeting, October 19 – 22, 2010, University of Mysore, ALGORITHMIC GENERATION OF SPECIALTY PROFILES FOR MEDICAL JOURNALS Pudovkin A.I Institute of Marine Biology, Vladivostok 690041, Russia; e-mail: [email protected] E. Garfield ThomsonReuters Scientific, 1500 Spring Garden Street, Philadelphia, PA 19130-4067, e-mail: [email protected] Abstract A procedure for generating a topical profile of a medical journal is proposed. The procedure consists in calculating of the relatedness index Rgeom of a target journal with all 50 JCR medical categories and identification of top-related ones. The set of highly related categories (3 or 5) may be regarded as the specialty profile of the target journal. We illustrate the method by considering the content of 7 medical journals, 6 specialized ones and a leading multi-scope journal: Annals of Surgery, Circulation, Clinical Infectious diseases, European Heart Journal, Gut, Shock, and New England Journal of Medicine. The data for our analyses are taken from the 2006 and 2009 JCR Science Edition ―Related Journals‖ listings for each medical category. It is shown that the resulting specialty profiles are quite stable in time and well correspond to JCR‘s assignment of journals to subject categories. JCR‘s category assignment is a heuristic procedure performed by an expert, while our procedure is comletely algorithmic. KeyWords: journal topical specification; medical journals; JCR; Journal Relatedness Indexes Introduction The problem of classification, that is, specialty characterization of journals is an old and difficult one (Katz and Hicks, 1995; Boyack et al., 2005; Klavans and Boyack, 2006; Leydesdorff, 2006; Zhang et al., 2010a, b). -
Extensive Microbial Diversity Within the Chicken Gut Microbiome Revealed by Metagenomics and Culture
Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture Rachel Gilroy1, Anuradha Ravi1, Maria Getino2, Isabella Pursley2, Daniel L. Horton2, Nabil-Fareed Alikhan1, Dave Baker1, Karim Gharbi3, Neil Hall3,4, Mick Watson5, Evelien M. Adriaenssens1, Ebenezer Foster-Nyarko1, Sheikh Jarju6, Arss Secka7, Martin Antonio6, Aharon Oren8, Roy R. Chaudhuri9, Roberto La Ragione2, Falk Hildebrand1,3 and Mark J. Pallen1,2,4 1 Quadram Institute Bioscience, Norwich, UK 2 School of Veterinary Medicine, University of Surrey, Guildford, UK 3 Earlham Institute, Norwich Research Park, Norwich, UK 4 University of East Anglia, Norwich, UK 5 Roslin Institute, University of Edinburgh, Edinburgh, UK 6 Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Banjul, The Gambia 7 West Africa Livestock Innovation Centre, Banjul, The Gambia 8 Department of Plant and Environmental Sciences, The Alexander Silberman Institute of Life Sciences, Edmond J. Safra Campus, Hebrew University of Jerusalem, Jerusalem, Israel 9 Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK ABSTRACT Background: The chicken is the most abundant food animal in the world. However, despite its importance, the chicken gut microbiome remains largely undefined. Here, we exploit culture-independent and culture-dependent approaches to reveal extensive taxonomic diversity within this complex microbial community. Results: We performed metagenomic sequencing of fifty chicken faecal samples from Submitted 4 December 2020 two breeds and analysed these, alongside all (n = 582) relevant publicly available Accepted 22 January 2021 chicken metagenomes, to cluster over 20 million non-redundant genes and to Published 6 April 2021 construct over 5,500 metagenome-assembled bacterial genomes. -
Targeting the Microbiota-Gut-Brain Axis
Author’s Accepted Manuscript Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice“Prebiotics for Stress-Related Disorders” Aurelijus Burokas, Silvia Arboleya, Rachel D. Moloney, Veronica L. Peterson, Kiera Murphy, Gerard Clarke, Catherine Stanton, Timothy G. www.elsevier.com/locate/journal Dinan, John F. Cryan PII: S0006-3223(17)30042-2 DOI: http://dx.doi.org/10.1016/j.biopsych.2016.12.031 Reference: BPS13098 To appear in: Biological Psychiatry Cite this article as: Aurelijus Burokas, Silvia Arboleya, Rachel D. Moloney, Veronica L. Peterson, Kiera Murphy, Gerard Clarke, Catherine Stanton, Timothy G. Dinan and John F. Cryan, Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice“Prebiotics for Stress-Related Disorders”, Biological Psychiatry, http://dx.doi.org/10.1016/j.biopsych.2016.12.031 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice Aurelijus Burokas1, Silvia Arboleya1,2*, Rachel D. Moloney1*, Veronica L. -
Pancreatic Diseases and Microbiota: a Literature Review and Future Perspectives
Journal of Clinical Medicine Review Pancreatic Diseases and Microbiota: A Literature Review and Future Perspectives Marcantonio Gesualdo , Felice Rizzi *, Silvia Bonetto, Stefano Rizza, Federico Cravero, Giorgio Maria Saracco and Claudio Giovanni De Angelis * Gastroenterology and Digestive Endoscopy Unit, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy; [email protected] (M.G.); [email protected] (S.B.); [email protected] (S.R.); [email protected] (F.C.); [email protected] (G.M.S.) * Correspondence: [email protected] (F.R.); [email protected] (C.G.D.A.) Received: 13 October 2020; Accepted: 30 October 2020; Published: 1 November 2020 Abstract: Gut microbiota represent an interesting worldwide research area. Several studies confirm that microbiota has a key role in human diseases, both intestinal (such as inflammatory bowel disease, celiac disease, intestinal infectious diseases, irritable bowel syndrome) and extra intestinal disorders (such as autism, multiple sclerosis, rheumatologic diseases). Nowadays, it is possible to manipulate microbiota by administering prebiotics, probiotics or synbiotics, through fecal microbiota transplantation in selected cases. In this scenario, pancreatic disorders might be influenced by gut microbiota and this relationship could be an innovative and inspiring field of research. However, data are still scarce and controversial. Microbiota manipulation could represent an important therapeutic strategy in the pancreatic diseases, in addition to standard therapies. In this review, we analyze current knowledge about correlation between gut microbiota and pancreatic diseases, by discussing on the one hand existing data and on the other hand future possible perspectives. Keywords: pancreatic diseases; microbiota; microbiome; gut microbiota; acute pancreatitis; chronic pancreatitis; diabetes mellitus; pancreatic ductal adenocarcinoma; pancreatic cystic neoplasms 1.